Reducing Time To PPQ By More Than 25%: Successful Tech Transfer Meets Commercial Needs
By Tracey Townsend, Associate Director, and Jozef Blaszczyk, Account Manager

Accelerating a technology transfer late in development can be critical when market demand outpaces existing manufacturing capacity. This case study explores how an experienced manufacturing partner condensed a traditionally 12–18 month tech transfer timeline to just nine months while preparing a complex biologic for commercial supply.
The program faced multiple, overlapping challenges: onboarding more than a dozen novel raw materials, qualifying new suppliers, navigating proprietary material authorization delays, and implementing enhanced intellectual property protections that required specialized training for a large cross‑functional team. Complicating matters further, emerging stability data during the first PPQ campaign revealed an opportunity for late‑stage process optimization to extend shelf life.
Rather than slowing progress, teams executed parallel workstreams—advancing regulatory filings while simultaneously optimizing the process and completing a second PPQ run. Both PPQ campaigns were approved for commercial use. The result was a significantly compressed path to validated manufacturing, enabling timely product availability while maintaining regulatory rigor, data integrity, and long‑term process robustness.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.